U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Lymphatic malformation 9

Summary

Lymphatic malformation-9 (LMPHM9) is an autosomal dominant disorder characterized by the onset of lower-extremity lymphedema in the first decades of life. Imaging may show lymph backflow and defects in lymph channel valves. There is variable expressivity and incomplete penetrance; female mutation carriers are more likely to show disease manifestations than male carriers (summary by Erickson et al., 2019). For a discussion of genetic heterogeneity of lymphatic malformation, see 153100. [from OMIM]

Genes See tests for all associated and related genes

  • Also known as: ADGRC1, CDHF9, FMI2, HFMI2, LMPHM9, ME2, CELSR1
    Summary: cadherin EGF LAG seven-pass G-type receptor 1

Clinical features

Help

Show allHide all

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.